UK scientists hope that lymphoma patients could benefit from a new drug that triggers the cancer-fighting properties of the body's own immune system, after highly promising early laboratory results. The University of Manchester researchers, who were funded by the charity Leukaemia & Lymphoma Research, have shown that, when used in conjunction with radiotherapy, the new drug is potentially four times more likely to lead to long-term survival than radiotherapy alone. Relapse is a common fate for many lymphoma patients and new treatments are desperately needed...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment